EFFECTS OF ALENDRONATE, HORMONE REPLACEMENT THERAPY AND COMBINATION TREATMENT ON HIP STRUCTURAL GEOMETRY IN OLDER WOMEN: A HIP STRUCTURE ANALYSIS- BASED RANDOMIZED CONTROLLED TRIAL
DOI:
https://doi.org/10.48047/cm8bbd81Keywords:
Hip structure analysis, Bone mineral density, Alendronate, Hormone replacement therapy, Osteoporosis treatmentAbstract
Background: The antiresorptive therapy can only partially explain the reduction in the fracture risk by augmenting the bone mineral density (BMD). Structural geometry is also an important factor in bone strength and it cannot be sufficiently measured alone with BMD. Purpose: To assess the impact of alendronate (ALN), hormone replacement therapy (HRT) and a combination of the two on the hip structural geometry through hip structure analysis (HSA). Methods: HSA was reanalyzed (in 76 older women) with the use of the dual-energy X-ray absorptiometry scan in a randomized, double-blind, placebo controlled trial followed up over a 3 year period. The HSA measurements of the cross-sectional area, cortical thickness, section modulus, and BMD of the femur neck were evaluated. Findings: There were no differences in baseline characteristics. The active treatments yielded great improvements on majority of the structural indices as compared to placebo. Combination therapy showed the highest increases of cross-sectional area, cortical thickness, section modulus and BMD by HSA, intermediary effects of ALN and minor yet significant effects by HRT. Conclusion: Antiresorptive therapy, and specifically a combination therapy, has a significant improvement in the geometry of the hip structure indicating an improvement in mechanical strength going beyond simple alteration in the BMD.
Downloads
References
Wasnich RD, Miller PD 2000 Antifracture efficacy of antiresorptive agents are related to changes in bone density. J Clin Endocrinol Metab 85: 231–236.
Cummings SR, Karpf DB, Harris F, Genant HK, Ensrud K, LaCroix AZ, Black DM 2002 Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs. Am J Med 112: 281–289.
Hochberg MC, Greenspan S, Wasnich RD, Miller P, Thompson DE, Ross PD 2002 Changes in bone density and turnover explain the reductions in incidence of nonvertebral fractures that occur during treatment with antiresorptive agents. J Clin Endocrinol Metab 87: 1586–1592.
Cranney A, Wells G, Willan A, Griffith L, Zytaruk N, Robinson V, Black D, Adachi J, Shea B, Tugwell P, Guyatt G, the Osteoporosis Methodology Group and the Osteoporosis Research Advisory Group 2002 Meta-analysis of alendronate for the treatment of postmenopausal women. Endocr Rev 23: 508–516.
Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC, Bauer DC, Genant HK, Haskell WL, Marcus R, Ott SM, Torner JC, Quandt SA, Reiss TF, Ensrud KE, Fracture Intervention Trial Research Group 1996 Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 348: 1535–1541.
Wells G, Tugwell P, Shea B, Guyatt G, Peterson J, Zytaruk N, Robinson V, Henry D, O'Connell D, Cranney A, The Osteoporosis Methodology Group, The Osteoporosis Research Advisory Group 2002 Meta-analysis of the efficacy of hormone replacement therapy in treating and preventing osteoporosis in postmenopausal women. Endocr Rev 23: 529–539.
Writing Group for the Women's Health Initiative Investigators 2002 Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA 288: 321–333.
The Women's Health Initiative Steering Committee 2004 Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: The Women's Health Initiative randomized controlled trial. JAMA 291: 1701–1712.
Greenspan SL, Resnick NM, Parker RA 2003 Combination therapy with hormone replacement and alendronate for prevention of bone loss in elderly women: A randomized, controlled trial. JAMA 289: 2525–2533.
Delmas PD, Seeman E 2004 Changes in bone mineral density explain little of the reduction in vertebral or nonvertebral fracture risk with anti-resorptive therapy. Bone 34: 599–604.
Hayes WC, Gerhart TN 1985 Biomechanics of bone: Applications for assessment of bone strength. In: WA Peck (ed.) Bone and Mineral Research, vol. 3. Annual Elsevier Science Publishers, Amsterdam, The Netherlands, pp. 259–294.
Martin BR, Burr DB 1984 Non-invasive measurement of long bone cross-sectional moment of inertia by photon absorptiometry. J Biomech 17: 195–201.
Beck TJ, Ruff CB, Scott WW Jr, Plato CC, Tobin JD 1992 Sex differences in geometry of the femoral neck with aging: A structural analysis of bone mineral data. Calcif Tissue Int 50: 24–29.
Beck TJ, Looker AC, Ruff CB, Sievanen H, Wahner HW 2000 Structural trends in the aging femoral neck and proximal shaft: Analysis of the third national health and nutrition examination survey dual-energy X-ray absorptiometry data. J Bone Miner Res 15: 2297–2304.
Beck TJ, Stone KL, Oreskovic TL, Hochberg MC, Nevitt MC, Genant HK, Cummings SR 2001 Effects of current and discontinued estrogen replacement therapy on hip structural geometry: The Study of Osteoporosis Fractures. J Bone Miner Res 16: 2103–2110.
Regan MM, Emond SK, Attardo MJ, Parker RA, Greenspan SL 2001 Why do elderly women discontinue hormone replacement therapy? J Womens Health Gender Based Med 10: 343–350.
Greenspan SL, Maitland LA, Myers ER, Krasnow MB, Kido TH 1994 Femoral bone loss progresses with age: A longitudinal study in women over age 65. J Bone Miner Res 9: 1959–1965.
Greenspan SL, Maitland-Ramsey L, Myers E 1996 Classification of osteoporosis in the elderly is dependent on site-specific analysis. Calcif Tissue Int 58: 409–414.
Lu Y, Mathur AK, Blunt BA, Glüer CC, Will AS, Fuerst TP, Jergas MD, Andriano KN, Cummings SR, Genant HK 1996 Dual X-ray absorptiometry quality control: Comparison of visual examination and process-control charts. J Bone Miner Res 11: 626–637.
Gere JM 2001 Mechanics of Materials, 5th ed, Brooks/Cole, Pacific Grove, CA, USA.
Nelson D, Berendes D, Hendricks S, Beck D 2000 Cross-sectional geometry, bone strength and bone mass in the proximal femur in African American and white postmenopausal women. J Bone Miner Res 15: 1992–1997.
Petit M, Beck T, Shults J, Zemel B, Foster B, Leonard M 2005 Proximal femur bone geometry is appropriately adapted to lean mass in overweight children and adolescents. Bone 36: 568–576.
Nelson DA, Pettifor JM, Barondess DA, Cody DD, Uusi-Rasi K, Beck TJ 2004 Comparison of cross-sectional geometry of the proximal femur in white and black women from Detroit and Johannesburg. J Bone Miner Res 19: 560–565.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
